Persistent Endocrine-Disrupting Chemicals and Fatty Liver Disease

被引:46
作者
Deierlein A.L. [1 ]
Rock S. [1 ]
Park S. [1 ]
机构
[1] College of Global Public Health, New York University, 715/719 Broadway 12th Floor, New York, 10003, NY
关键词
Fatty liver disease; Persistent endocrine-disrupting chemicals; Polychlorinated biphenyl; TCDD;
D O I
10.1007/s40572-017-0166-8
中图分类号
学科分类号
摘要
Purpose of Review: Non-alcoholic fatty liver disease (NAFLD) is the most prominent chronic liver disease in Western countries, affecting approximately 25% of the population worldwide. Sex-specific differences in the development of NAFLD are apparent. While obesity and insulin resistance are major contributors to the increasing prevalence of NAFLD, a growing body of literature suggests that exposure to persistent endocrine-disrupting chemicals (pEDCs) may also play a role. This review summarizes recent (2011 and later) scientific literature investigating exposures to pEDCs, specifically persistent organic pollutants (POPs), and NAFLD, with a focus on sex-specific associations. Recent Findings: The overwhelming majority of studies were conducted in single-sex animal models and provide biological evidence that exposures to 2,3,7,8-tetrachlorodibenzo-p-dioxin polychlorinated biphenyls, and other POPs or POP mixtures are negatively associated with liver health. There were four cross-sectional epidemiological studies in humans that reported associations for several POPs, including polychlorinated biphenyls and perfluorinated chemicals, with elevated liver enzymes. Only one of these studies, using a sample of gastric bypass surgery patients, examined sex-specific associations of POPs and liver enzymes, finding adverse associations among women only. The noticeable lack of studies investigating how differences (i.e., biochemical, physiological, and behavioral) between men and women may influence associations of pEDCs and NAFLD represents a large research gap in environmental health. Sexual dimorphism in metabolic processes throughout the body, including the liver, is established but often overlooked in the designs and analyses of studies. Other factors identified in this review that may also act to modulate associations of environmental chemicals and NAFLD are reproductive status and dietary nutrient intakes, which also remain understudied in the literature. Summary: Despite knowledge of sexual dimorphism in the actions of pEDCs, as well as in metabolic processes related to NAFLD development, few experimental or epidemiological studies have investigated sex-dependent associations. Future studies, especially those in humans, should be designed to address this research need. Consideration of other factors, such as reproductive status, dietary intakes, and mixtures of chemicals with varying endocrine-disrupting capabilities, should be explored. © 2017, Springer International Publishing AG.
引用
收藏
页码:439 / 449
页数:10
相关论文
共 50 条
[31]   Research Progress of Pyroptosis in Fatty Liver Disease [J].
Li, Rongxuan ;
Xue, Weiyue ;
Wei, Huiting ;
Fan, Qingqing ;
Li, Xiang ;
Qiu, Ye ;
Cui, Di .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (17)
[32]   Editorial: obesity, Smoking, and Fatty liver disease [J].
Sinha-Hikim, Amiya P. ;
Mahata, Sushil K. .
FRONTIERS IN ENDOCRINOLOGY, 2018, 9
[33]   Nonalcoholic Fatty Liver Disease and HIV Infection [J].
Vallet-Pichard, Anais ;
Mallet, Vincent ;
Pol, Stanislas .
SEMINARS IN LIVER DISEASE, 2012, 32 (02) :158-166
[34]   Redefining fatty liver disease classification in 2020 [J].
Valenti, Luca ;
Pelusi, Serena .
LIVER INTERNATIONAL, 2020, 40 (05) :1016-1017
[35]   Comparison between metabolic-associated fatty liver disease and nonalcoholic fatty liver disease: From nomenclature to clinical outcomes [J].
Alomari, Mohammad ;
Rashid, Mamoon Ur ;
Chadalavada, Pravallika ;
Ragheb, Jonathan ;
Zafar, Hammad ;
Suarez, Zoilo Karim ;
Khazaaleh, Shrouq ;
Gonzalez, Adalberto Jose ;
Castro, Fernando J. .
WORLD JOURNAL OF HEPATOLOGY, 2023, 15 (04) :477-496
[36]   Parental non-alcoholic fatty liver disease increases risk of non-alcoholic fatty liver disease in offspring [J].
Long, Michelle T. ;
Gurary, Ellen B. ;
Massaro, Joseph M. ;
Ma, Jiantao ;
Hoffmann, Udo ;
Chung, Raymond T. ;
Benjamin, Emelia J. ;
Loomba, Rohit .
LIVER INTERNATIONAL, 2019, 39 (04) :740-747
[37]   Diagnostic Performance of Ultrasonography in Detecting Fatty Liver Disease in Comparison with Fibroscan in People Suspected of Fatty Liver [J].
Kamali, Leila ;
Adibi, Atoosa ;
Ebrahimian, Shadi ;
Jafari, Fahime ;
Sharifi, Mohsen .
ADVANCED BIOMEDICAL RESEARCH, 2019, 8 (01) :69
[38]   Liver-derived metabolites as signaling molecules in fatty liver disease [J].
Umur Keles ;
Jin Rong Ow ;
Katharina Barbara Kuentzel ;
Li Na Zhao ;
Philipp Kaldis .
Cellular and Molecular Life Sciences, 2023, 80
[39]   Liver-derived metabolites as signaling molecules in fatty liver disease [J].
Keles, Umur ;
Ow, Jin Rong ;
Kuentzel, Katharina Barbara ;
Zhao, Li Na ;
Kaldis, Philipp .
CELLULAR AND MOLECULAR LIFE SCIENCES, 2023, 80 (01)
[40]   Omega-3 fatty acids and metabolic partitioning of fatty acids within the liver in the context of nonalcoholic fatty liver disease [J].
Calder, Philip C. .
CURRENT OPINION IN CLINICAL NUTRITION AND METABOLIC CARE, 2022, 25 (04) :248-255